INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 198 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,850,000 | -23.3% | 44,625 | -11.4% | 0.06% | -27.6% |
| Q2 2020 | $2,412,000 | -23.5% | 50,342 | +0.5% | 0.09% | -48.8% |
| Q1 2020 | $3,155,000 | -49.2% | 50,111 | +0.0% | 0.17% | -40.6% |
| Q4 2019 | $6,208,000 | +80.0% | 50,096 | -3.6% | 0.29% | +50.5% |
| Q3 2019 | $3,449,000 | -10.3% | 51,968 | +7.6% | 0.19% | 0.0% |
| Q2 2019 | $3,844,000 | -34.8% | 48,305 | -8.4% | 0.19% | -40.1% |
| Q1 2019 | $5,899,000 | – | 52,740 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |